Thujone improves glucose homeostasis in streptozotocin-induced diabetic rats through activation of Akt/glycogen synthase kinase-3β signaling pathway

Journal of Experimental and Integrative Medicine

Volumn 5, Issue 1, 2015, Pages 30-35

  Alkhateeb, Hakam Hasan ^a  

^a YARMOUK UNIVERSITY   (Jordan)

Author keywords

Akt; Glycogen; Glycogen synthase; Glycogen synthase kinase 3 ; Insulin resistance

Indexed keywords

ABSINTHOL; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; PROTEIN KINASE B; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCOGEN LIVER LEVEL; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PILOT STUDY; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 85030859950     PISSN: 13094572     EISSN: 21463298     Source Type: Journal    
DOI: 10.5455/jeim.260115.or.122     Document Type: Article

References (29)

1. Ojo O, Brooke J. Evaluation of the role of enteral nutrition in managing patients with diabetes: A systematic review. Nutrients 2014;6:5142-52.
2. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990;322:223-8.
3. Karim S, Liaskou E, Fear J, Garg A, Reynolds G, Claridge L, et al. Dysregulated hepatic expression of glucose transporters in chronic disease: Contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptake. Am J Physiol Gastrointest Liver Physiol 2014;307:G1180-90.
4. König M, Bulik S, Holzhütter HG. Quantifying the contribution of the liver to glucose homeostasis: A detailed kinetic model of human hepatic glucose metabolism. PLoS Comput Biol 2012;8:e1002577.
5. Krssak M, Brehm A, Bernroider E, Anderwald C, Nowotny P, Dalla Man C, et al. Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 2004;53:3048-56.
6. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, et al. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: Additional evidence for a defect in hepatic glucokinase activity. Diabetes 2001;50:1351-62.
7. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, et al. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: Evidence for a defect in hepatic glucokinase activity. Diabetes 2000;49:272-83.
8. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: Insights into insulin action. Nat Rev Mol Cell Biol 2006;7:85-96.
9. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 2002;13:444-51.
10. Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 2009;10:405-18.
11. Lizcano JM, Alessi DR. The insulin signalling pathway. Curr Biol 2002;12:R236-8.
12. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995;378:785-9.
13. Brozinick JT Jr, Roberts BR, Dohm GL. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: Potential role in insulin resistance. Diabetes 2003;52:935-41.
14. Alkhateeb H, Bonen A. Thujone, a component of medicinal herbs, rescues palmitate-induced insulin resistance in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2010;299:R804-12.
15. Alkhateeb H, Chabowski A, Glatz JF, Luiken JF, Bonen A. Two phases of palmitate-induced insulin resistance in skeletal muscle: Impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity. Am J Physiol Endocrinol Metab 2007;293:E783-93.
16. Ussher JR, Koves TR, Cadete VJ, Zhang L, Jaswal JS, Swyrd SJ, et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 2010;59:2453-64.
17. Misra P, Chakrabarti R. The role of AMP kinase in diabetes. Indian J Med Res 2007;125:389-98.
18. Lipscombe LL. Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes. Evid Based Med 2009;14:168.
19. Tang LQ, Wei W, Chen LM, Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 2006;108:109-15.
20. Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 2008;93:2559-65.
21. Alkhateeb H. In vivo anti-diabetic activity of thujone in streptozotocininduced diabetic rats. 7th World Congress on Diabetes Prevention and its Complications. Madrid, Spain; 2012.
22. Roghani M, Baluchnejadmojarad T. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology 2010;17:55-9.
23. Xie X, Li W, Lan T, Liu W, Peng J, Huang K, et al. Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway. Endocr J 2011;58:761-8.
24. Saltiel AR. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001;104:517-29.
25. Frizzo ME. Putative role of glycogen as a peripheral biomarker of GSK3β activity. Med Hypotheses 2013;81:376-8.
26. Li Z, Ma L, Chen X, Li Y, Li S, Zhang J, et al. Glycogen synthase kinase-3: A key kinase in retinal neuron apoptosis in early diabetic retinopathy. Chin Med J (Engl) 2014;127:3464-70.
27. Ruddock MW, Stein A, Landaker E, Park J, Cooksey RC, McClain D, et al. Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling. J Biochem 2008;144:599-607.
28. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001;359:1-16.
29. Balaraman Y, Limaye AR, Levey AI, Srinivasan S. Glycogen synthase kinase 3beta and Alzheimer's disease: Pathophysiological and therapeutic significance. Cell Mol Life Sci 2006;63:1226-35.